MIRA Pharmaceuticals, Inc. (MIRA) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -1.2M | -1.14M | -1.1M | -799.65K | -1.63M | -1.81M | -1.84M | -863.93K | -1.05M | -2.14M | -1.76M | -660.81K |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | 26.3% | 37.12% | 40.45% | 7.44% | -55.31% | 15.46% | -4.59% | -30.74% | 2.4% | -118.89% | - | - |
| Net Income | -1.15M | 15.57M | -22.69M | -1.54M | -1.78M | -2.4M | -2.04M | -1.69M | -1.72M | -5.79M | -3.59M | -1.27M |
| Depreciation & Amortization | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 0 | 4.95M | 0 | 489.57K | 874.81K | 546.78K | 269.01K | 604.8K | 500.21K | 0 | 1.45M | 0 |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 199.17K | -21.74M | 21.77M | 0 | 0 | 0 | 0 | 145.88K | 0 | 3.94M | 414.24K | 1.03M |
| Working Capital Changes | -250.3K | 79.07K | -174.06K | 248.5K | -721.06K | 47.88K | -67.25K | 76.71K | 168.03K | -288.36K | -39.83K | -427.79K |
| Change in Receivables | -161.5K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 11.86K | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -95.19K | 0 | -214.53K | 192.28K | -617.18K | 0 | -89.31K | 145.88K | 97.7K | -241.01K | 0 | 0 |
| Cash from Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | -330.61K | 4.84M | 3.01M | 323.84K | 3.38K | 493.4K | 3.16M | 159.01K | -24.34K | 869.35K | 7.6M | 684.29K |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 14.47K | -14.47K | 0 | 0 | 2.24M | 0 | -219.54K |
| Equity Issued (Net) | 0 | -3.34M | 3.01M | 323.84K | 3.38K | 478.93K | 3.13M | 0 | 0 | -1.35M | 9.05M | -163.68K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -330.61K | 8.18M | 0 | 0 | 0 | 0 | 47.74K | 159.01K | -24.34K | -19.15K | -1.45M | 1.07M |
| Net Change in Cash | -1.53M | 3.71M | 1.91M | -475.81K | -1.63M | -1.31M | 1.32M | -704.91K | -1.07M | -1.27M | 5.84M | 23.47K |
| Free Cash Flow | -1.2M | -1.14M | -1.1M | -799.65K | -1.63M | -1.81M | -1.84M | -863.93K | -1.05M | -2.14M | -1.76M | -660.81K |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | 26.3% | 37.12% | 40.45% | 7.44% | -55.31% | 15.46% | -4.59% | -30.74% | 2.4% | -118.89% | - | - |
| FCF per Share | -0.03 | -0.05 | -0.06 | -0.05 | -0.10 | -0.12 | -0.12 | -0.06 | -0.05 | -0.14 | -0.12 | -0.04 |
| FCF Conversion (FCF/Net Income) | 1.04x | 0.19x | 0.96x | 0.52x | 0.91x | 0.75x | 0.90x | 0.51x | 0.61x | 0.37x | 0.49x | 0.52x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |